Fig. 2 | Scientific Reports

Fig. 2

From: Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment

Fig. 2

Multiplexing the Lumit Human IL-1β Immunoassay with the Caspase-Glo 1 Inflammasome Assay. MCF-12A and MDA-MB-231 cells were treated with 100 nM PTX for 24 h. Statistical significance: “*” symbol was used for statistical comparisons between the levels of caspase-1 secreted in each experimental condition; “#” symbol was used for statistical comparisons between the levels of IL-1β secreted in each experimental condition; ** p < 0.01, *** p < 0.001, ## p < 0.01 and #### p < 0.0001 (n = 3, biological replicates).

Back to article page